Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 3 | 2020 | 214 | 1.010 |
Why?
|
| Osteogenesis | 4 | 2020 | 168 | 1.000 |
Why?
|
| Growth Plate | 2 | 2022 | 20 | 0.890 |
Why?
|
| Chondrogenesis | 3 | 2022 | 29 | 0.870 |
Why?
|
| Chondrocytes | 3 | 2022 | 51 | 0.750 |
Why?
|
| Bone and Bones | 5 | 2025 | 311 | 0.740 |
Why?
|
| Bone Development | 4 | 2025 | 60 | 0.730 |
Why?
|
| Osteoblasts | 5 | 2025 | 166 | 0.670 |
Why?
|
| Zebrafish | 2 | 2022 | 422 | 0.660 |
Why?
|
| Signal Transduction | 5 | 2020 | 4917 | 0.660 |
Why?
|
| Bone Diseases | 1 | 2020 | 45 | 0.640 |
Why?
|
| Bone Density | 2 | 2025 | 377 | 0.570 |
Why?
|
| Cell Differentiation | 8 | 2025 | 2026 | 0.480 |
Why?
|
| Losartan | 1 | 2015 | 36 | 0.460 |
Why?
|
| Stem Cells | 2 | 2020 | 748 | 0.400 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 12 | 0.380 |
Why?
|
| Transforming Growth Factor beta | 3 | 2025 | 484 | 0.380 |
Why?
|
| Osteoclasts | 6 | 2025 | 74 | 0.380 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 79 | 0.370 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 334 | 0.340 |
Why?
|
| Cartilage | 3 | 2022 | 51 | 0.340 |
Why?
|
| RANK Ligand | 2 | 2025 | 54 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 297 | 0.340 |
Why?
|
| Osteochondrodysplasias | 2 | 2022 | 68 | 0.310 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2524 | 0.310 |
Why?
|
| Bone Neoplasms | 3 | 2020 | 447 | 0.310 |
Why?
|
| MicroRNAs | 2 | 2017 | 945 | 0.310 |
Why?
|
| Animals | 20 | 2025 | 36222 | 0.260 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 1041 | 0.260 |
Why?
|
| Mice | 15 | 2025 | 18936 | 0.240 |
Why?
|
| DNA Helicases | 2 | 2025 | 245 | 0.230 |
Why?
|
| Jagged-1 Protein | 2 | 2017 | 53 | 0.230 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 19 | 0.230 |
Why?
|
| SOX9 Transcription Factor | 2 | 2017 | 86 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1612 | 0.220 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2025 | 172 | 0.200 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1341 | 0.160 |
Why?
|
| Diphosphonates | 1 | 2020 | 43 | 0.160 |
Why?
|
| Nitrogen | 1 | 2020 | 148 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1152 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3979 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4760 | 0.140 |
Why?
|
| Radiography | 3 | 2015 | 824 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 2651 | 0.140 |
Why?
|
| Homeostasis | 2 | 2020 | 748 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 206 | 0.140 |
Why?
|
| Osteocytes | 1 | 2017 | 14 | 0.130 |
Why?
|
| Micrognathism | 2 | 2017 | 68 | 0.130 |
Why?
|
| Hand Deformities, Congenital | 1 | 2017 | 95 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2016 | 81 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 186 | 0.120 |
Why?
|
| Limb Deformities, Congenital | 2 | 2015 | 112 | 0.120 |
Why?
|
| Angiotensins | 1 | 2015 | 8 | 0.120 |
Why?
|
| RAW 264.7 Cells | 1 | 2015 | 47 | 0.120 |
Why?
|
| Actins | 1 | 2017 | 344 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2017 | 946 | 0.110 |
Why?
|
| RecQ Helicases | 1 | 2015 | 64 | 0.110 |
Why?
|
| Hypertrophy | 1 | 2015 | 102 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 97 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 115 | 0.110 |
Why?
|
| Exome | 3 | 2017 | 1086 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 2145 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 745 | 0.100 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.100 |
Why?
|
| Flavoproteins | 1 | 2013 | 19 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 46 | 0.100 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 14 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 60 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 59 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 46 | 0.100 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Osteosclerosis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Mutation | 4 | 2017 | 6343 | 0.100 |
Why?
|
| Osteopetrosis | 1 | 2012 | 13 | 0.100 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2012 | 36 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 88 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1049 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1072 | 0.090 |
Why?
|
| Collagen Type I | 2 | 2025 | 126 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1707 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2012 | 141 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 788 | 0.080 |
Why?
|
| Intellectual Disability | 1 | 2017 | 1096 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2017 | 2720 | 0.080 |
Why?
|
| Organ Size | 2 | 2025 | 464 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2012 | 264 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1849 | 0.070 |
Why?
|
| Humans | 14 | 2024 | 133373 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Retinoid X Receptors | 1 | 2006 | 32 | 0.060 |
Why?
|
| Phenobarbital | 1 | 2006 | 35 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3363 | 0.060 |
Why?
|
| Lysine | 1 | 2006 | 207 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4823 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 13 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| Tibia | 1 | 2025 | 83 | 0.060 |
Why?
|
| X-Ray Microtomography | 1 | 2025 | 96 | 0.060 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 274 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 127 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 396 | 0.050 |
Why?
|
| Histones | 1 | 2006 | 572 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3960 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2006 | 872 | 0.040 |
Why?
|
| Alendronate | 1 | 2020 | 21 | 0.040 |
Why?
|
| Female | 5 | 2025 | 71503 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 1051 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 3131 | 0.040 |
Why?
|
| Collagen Type II | 1 | 2017 | 25 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 99 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 175 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 124 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 84 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 219 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 321 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1571 | 0.030 |
Why?
|
| Face | 1 | 2017 | 190 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 432 | 0.030 |
Why?
|
| Base Sequence | 2 | 2013 | 3153 | 0.030 |
Why?
|
| Patella | 1 | 2015 | 28 | 0.030 |
Why?
|
| Radius | 1 | 2015 | 36 | 0.030 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2015 | 47 | 0.030 |
Why?
|
| Anal Canal | 1 | 2015 | 82 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 562 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 731 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1013 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 824 | 0.030 |
Why?
|
| Dwarfism | 1 | 2015 | 104 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 786 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 127 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 1830 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 24 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1730 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 860 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 625 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2013 | 52 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2015 | 134 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1852 | 0.020 |
Why?
|
| Femur | 1 | 2013 | 75 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2013 | 59 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 106 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 250 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 1608 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 120 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 201 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2853 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 372 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 366 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 631 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1325 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2246 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 890 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2785 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 2720 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2006 | 11 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2006 | 50 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2006 | 40 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 153 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2006 | 30 | 0.020 |
Why?
|
| Methylation | 1 | 2006 | 232 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1915 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 329 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 293 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 245 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 787 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 500 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1378 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4577 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1147 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 1757 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 20573 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3794 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 1001 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 13243 | 0.010 |
Why?
|
| Child | 1 | 2017 | 25868 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 14873 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 1411 | 0.010 |
Why?
|
| Male | 1 | 2017 | 65592 | 0.010 |
Why?
|